Evidence map›Paper›PMID 16641463›Full record

ArticleAntimicrobial agents and chemotherapy2006

Comparative in vitro efficacies of various catheter lock solutions.

Robert J Sherertz, Michael S Boger, Casey A Collins, Lori Mason, Issam I Raad

Registry-linked trialAbstract readComparative Study
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01592032 (Concentration and Antibiotic Activity in Antibiotic Lock Solutions), which is not on this map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01592032 phase4unknown statusnot on this mapstarted 2012, after this paper: background citation

Concentration and Antibiotic Activity in Antibiotic Lock Solutions

TypeinterventionalSponsorClinica Universidad de Navarra, Universidad de NavarraRan2012 to 2015Enrolled125ConditionsCatheter-Related Infections, Bacteremia.ArmsVancomycin antimicrobial-lock solution, Teicoplanin antimicrobial-lock solution, Linezolid antimicrobial-lock solution, Daptomycin antimicrobial-lock solution, Tigecycline antimicrobial-lock solution
3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Robert J SherertzSection on Infectious Diseases, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27517, USA. sherertz@wfubmc.edu
Michael S Boger
Casey A Collins
Lori Mason
Issam I Raad

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MEDTA (minocycline-edetate calcium disodium), taurolidine (2%)-polyvinylpyrolidine (5%) (T/PVP), and ethanol as potential catheter lock solutions have a unique mechanism of action, broad-spectrum activity, and anticoagulant properties. Traditional lock solutions minocycline (M), rifampin (R), ciprofloxacin (C), and vancomycin, except pharmacologic concentrations of C and R and of M and R, were less effective than MEDTA and T/PVP.

Indexed as

Anti-Bacterial AgentsAnticoagulantsAnti-Infective AgentsCandida albicansCatheterizationCatheters, IndwellingCiprofloxacinColony Count, MicrobialDose-Response Relationship, DrugDrug SynergismDrug Therapy, CombinationEdetic AcidEthanolHumansIn Vitro TechniquesMicrobial Sensitivity TestsAnti-Bacterial AgentsAnticoagulantsAnti-Infective AgentsCiprofloxacinEdetic AcidEthanolMinocyclinePharmaceutical PreparationsRifampinSolutionsTaurinetaurolidineThiadiazinesVancomycin

Identifiers

PMID16641463
PMCPMC1472229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.